Sleep Disorders Trial, Recruiting NCT05124392 Sponsor: Massachusetts General Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05124392
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 85 years old
  • People who meet at least one of the following: they are a known carrier of a specific genetic mutation (in the PRNP gene); they have a biological parent and other family members who have had a prion disease diagnosis; or they are a family member who does not carry the mutation, or an unrelated volunteer who previously enrolled as a control
  • People who are healthy enough to have a blood draw, a lumbar puncture (spinal fluid sample), and cognitive (thinking and memory) testing
  • People with adequate vision and hearing to complete cognitive testing
  • People who are fluent in English
  • People who have had at least 5 years of formal education
  • People who are able to understand and agree to what the study involves and can follow the study procedures
  • People who have no medical reasons preventing them from having an MRI scan — this requirement applies to PRNP mutation carriers only

Who may not be able to join:

  • People who have a brain or nervous system condition other than asymptomatic (no symptoms) or early prion disease — for example, stroke, brain tumour, multiple sclerosis, serious head injury with lasting effects, Alzheimer's disease, Parkinson's disease, or other known conditions that cause progressive brain deterioration
  • People who have had a problem with alcohol or other substance misuse or dependence within the past two years
  • People who have a significant ongoing illness, an unstable health condition, or who are pregnant, where participation could pose a safety risk or affect their ability to take part
  • People who have a blood clotting disorder or who are taking blood-thinning medications (such as Coumadin/warfarin) that raise the risk of complications during blood draws or spinal fluid collection, where certain blood test results fall outside an acceptable range (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven E Arnold, MD, MGH

Phone: 617-726-4026

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2017
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CSF YKL40; CSF Tau; CSF Nfl; CSF GFAP; CSF Prion protein; CSF Prion biomarkers; Cognition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov